A whole food, plant-based randomized controlled trial in metastatic breast cancer: feasibility, nutrient, and patient-reported outcomesClinical Trial Published on 2024-03-302024-09-05 Journal: Breast cancer research and treatment [Category] update2024, [키워드] Breast cancer Metastatic breast cancer nutrition obesity Patient-reported outcomes plant-based Quality of life Vegan diet [DOI] 10.1007/s10549-024-07284-z PMC 바로가기 [Article Type] Clinical Trial
Efficacy and delivery strategies of the dual Rac/Cdc42 inhibitor MBQ-167 in HER2 overexpressing breast cancerOriginal Research Published on 2024-03-152024-09-05 Journal: Translational Oncology [Category] update2024, [키워드] HER2-type breast cancer MBQ-167 Metastatic breast cancer Rac, Cdc42 Trastuzumab [DOI] 10.1016/j.tranon.2024.101928 PMC 바로가기 [Article Type] Original Research
Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2): an open-label, multicenter, phase II trialarticle Published on 2022-02-092024-09-02 Journal: Breast Cancer Research and Treatment [Category] 대상포진, [키워드] Afatinib ErbB HER2 Metastatic breast cancer resistance [DOI] 10.1007/s10549-021-06449-4 PMC 바로가기 [Article Type] article
Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study)Original Research Published on 2021-12-152024-09-04 Journal: Therapeutic Advances in Medical Oncology [Category] 대상포진, [키워드] DHP107 First-line HER2-negative Metastatic breast cancer oral paclitaxel [DOI] 10.1177/17588359211061989 PMC 바로가기 [Article Type] Original Research
PRO B: evaluating the effect of an alarm-based patient-reported outcome monitoring compared with usual care in metastatic breast cancer patients—study protocol for a randomised controlled trialPRO B: 전이성 유방암 환자에서 일반 치료와 비교하여 경보 기반 환자 보고 결과 모니터링의 효과 평가 - 무작위 대조 시험을 위한 연구 프로토콜Study Protocol Published on 2021-09-282022-09-10 Journal: Trials [Category] SARS, 임상, [키워드] 1:1 acute disease alarm among others approach ARMS Breast cancer breast cancer patient clinical Clinical practice Complete Contact control arm Controlled trial controls determined by develop disease domain elongation emergency room Endpoint enrolment ePROs fatigue female form Health apps hospitalisation hospitalisations identify include independent intervene Intervention intervention arm intervention group less life Metastatic breast cancer metastatic disease mobile devices outcome Patient Patient-reported outcomes Personalised medicine positive Primary outcome pros protocol Quality of life randomisation randomised randomised controlled trial receive recruited reported symptom reported symptoms required Research secondary Secondary endpoints selected Society supplementary material survival the patient transfer Treatment Trial Trigger usual care Value-based health care [DOI] 10.1186/s13063-021-05642-6 PMC 바로가기 [Article Type] Study Protocol
Exploring metastatic breast cancer treatment changes during COVID-19 pandemicArticle Published on 2021-07-012023-07-06 Journal: Journal of chemotherapy (Florence, Italy) [Category] SARS, [키워드] antiHer2 agents Chemotherapy COVID-19 pandemic elderly patients endocrine therapy. Metastatic breast cancer [DOI] 10.1080/1120009X.2020.1829328
Severe Cellular Immunodeficiency Triggered by the CDK4/6 Inhibitor PalbociclibCase Report Published on 2020-02-202024-09-04 Journal: Clinical breast cancer [Category] 대상포진, [키워드] lymphopenia Metastatic breast cancer opportunistic Infections pharmacovigilance pneumocystosis [DOI] 10.1016/j.clbc.2020.01.009 PMC 바로가기 [Article Type] Case Report
Outcomes of re-treatment with first-line trastuzumab plus a taxane in HER2 positive metastatic breast cancer patients after (neo)adjuvant trastuzumab: A prospective multicenter studyClinical Research Paper Published on 2016-08-022024-09-02 Journal: Oncotarget [Category] 대상포진, [키워드] (neo)adjuvant trastuzumab human epidermal growth factor receptor 2 (HER2) Metastatic breast cancer re-treatment Trastuzumab [DOI] 10.18632/oncotarget.9331 PMC 바로가기 [Article Type] Clinical Research Paper